Injection Pen Global Market Sees Growth Rate Of 7% Through 2026

The global injection pen market size is expected to grow from $43.56 billion in 2021 to $46.70 billion in 2022 at a compound annual growth rate (CAGR) of 7.22%. The growth in the injection pen market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global injection pens market size is expected to reach $62.05 billion in 2026 at a CAGR of 7.36%.

What is the Global Injection Pen Market?

The injection pen market consists of sales of injection pens by entities (organizations, sole traders, and partnerships) that are used for injecting medication under the skin. Injection pens make injectable medicine such as insulin easier and more convenient to use, thus increasing patient adherence. The pens contain a cartridge, a dial to measure dosage, and a disposable needle and allow more simple, accurate, and convenient delivery than a vial and syringe.

Get a Sample of the global injection pen market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=5676&type=smp

What drives the Global Injection Pen Market?

The rise in prevalence of diseases such as diabetes and arthritis is contributing to the growth of the injection pen market. Factors such as an increase in the size of the obese population, physical inactivity, unhealthy eating habits, and increasing age lead to an increase in the global prevalence of diabetes. For instance, as per the International Diabetes Federation (IDF), the global diabetes prevalence population, by 2040, is expected to reach about 640 million. Furthermore, in the population of emerging countries such as India, about 69 million people are diabetic, by 2030, this number is expected to rise to 100 million. Therefore, the rise in the prevalence of diseases such as diabetes and arthritis will drive the growth of the injection pen market.

Get the full global injection pen industry report here

Global Injection Pen Market Segments
The global injection pen market is segmented:
By Product Type: Disposable Injection Pens, Reusable Injection Pens
By Therapy: Diabetes, Fertility, Osteoporosis, Growth Hormone Therapy, Others
By End-User: Home Care, Hospital and Clinics
By Geography: The regions covered in the injection pen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Injection Pen Global Market Report 2022provides market size and growth forecasts for the global injection pen market, global injection pen market share, injection pen market segments and geographies, injection pen market competitive landscape including leading competitors’ revenues, profiles and injection pen market shares. The injection pen market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Global Injection Pen Industry Playersinclude Novo Nordisk A/S, Ypsomed Holding AG, Sanofi, Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd, Owen Mumford, Sulzer Ltd, Sun Pharmaceutical Industries Ltd, Pfizer, Lupin Ltd, Wockhardt Ltd, AptarGroup, Inc., Novartis AG, Gerresheimer AG, SHL Medical AG, Boehringer Ingelhem, Nemera France SA, Companion Medical, Jiangsu Delfu Medical Devices Co., Ltd, Haselmeier, GlaxoSmithKline plc, Stat Medical Devices, DuPont, and Emperra GmbH E-Health Technologies. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.